Clinical Trial

Evaluation of the Effectiveness of the Genomics & Science DOJO 3.0 Learning Method in Improving Research Skills and Scientific Writing Among Researchers in Indonesia

Study acronym: DOJO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 15, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to rigorously evaluate the effectiveness of the DOJO 3.0 learning methodology in enhancing research skills and scientific writing among researchers in Indonesia compared to non-DOJO learning method. The main questions it aims to answer are: How effective is the Dojo 3.0 methodology in improving participants' research skills and scientific writing, including critical thinking, data analysis ability, knowledge acquisition, and scientific manuscript quality and publication progress? How do participants' experiences, perceptions of the learning process and teaching quality, as well as their engagement, performance, and learning behaviors, differ between the intervention (DOJO) and control groups throughout the program? Researchers will compare two groups, control group and intervention group to see if there is a significant difference between these two groups. Standard learning method Non-DOJO (Control) DOJO learning method (Intervention) For the intervention group, participants will participate in Shinjitsu class, an interactive dynamic lecture with real time engagement, an offline minicamp session with lecture that is more intense, intentionally more provocative and dynamic, wounded healer, shinjitsu ninja obstacles, shinjitsu ninja run, sparring and Tournament.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-16
Trial Details
NCT Number NCT07607301
Lead Sponsor Summit Institute for Development, Indonesia
Collaborators: Oxford University Clinical Research Unit Indonesia
Conditions Workshop, Critical Thinking Skill, Data Analysis Skill, Personal Empowerment, Manuscript Quality, Genomics, Science, Research Publication +2 more
Enrollment 96 participants
Start Date 2026-06-04
Primary Completion 2026-07 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-15